Open AccessClinical experience with biphasic insulin aspart in people with type 2 diabetes: Results from the Libya cohort of the A 1 chieve study
Author(s) -
Issam Hajjaji,
Ibrahim H. Sherif,
Aisha Elazrag,
Suhair Jaber,
Praful Chakkarwar,
Salem A Eltabal
Publication year - 2013
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.122062
Subject(s) - insulin aspart , medicine , insulin detemir , insulin , cohort , type 2 diabetes , diabetes mellitus , basal insulin , endocrinology , hypoglycemia
The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents.